Purpose
|
Desvenlafaxine (O-desmethylvenlafaxine) the major active metabolite of venlafaxine, is an antidepressant from the serotonin-norepinephrine reuptake inhibitor (SNRI class). Desvenlafaxine may be used to treat major depressive disorder and is being studied for use in the management of vasomotor symptoms in postmenopausal women. It is formulated as an extended release tablet. FDA approved in 2008.
|
Characteristics
|
Tradename: PRISTIQ Source of Compound: synthetic, WY-45233 Target: Noradrenaline uptake inhibitor,Serotonin uptake inhibitor Receptor: Sodium-dependent noradrenaline transporter,Sodium-dependent serotonin transporter Status: USAN, INN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C16H25NO2
|
Solubility
|
In water, 3700 mg/L .
|